Concepedia

Jake Delmore

JD

Statistics

Publications

22

Citations

4.5K

H-Index

21

Active since

1994

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Pfizer (United States)

VA Boston Healthcare System

Jake Delmore is an author at Dana-Farber Cancer Institute specializing in medicine, pharmacology, and oncology.

Publications per year

1994–2023

22

Publications

22

BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc

Jake Delmore, Ghayas C. Issa, Madeleine E. Lemieux et al. · Cell · 2011 · 2.8K citations · Full text

, , +10

Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity

Douglas W. McMillin, Jake Delmore, Ellen Weisberg et al. · Nature Medicine · 2010 · 315 citations · Full text

, , +16

Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice

Emily Cokorinos, Jake Delmore, Allan R. Reyes et al. · Cell Metabolism · 2017 · 266 citations · Full text

, , +13

Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications

Jana Jakubı́ková, Sophia Adamia, Maria Kost‐Alimova et al. · Blood · 2011 · 154 citations · Full text

, , +16

Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models

Ryan M. Esquejo, Christopher T. Salatto, Jake Delmore et al. · EBioMedicine · 2018 · 150 citations · Full text

, , +17

1–5 of 22